Komori
General Meetings of Shareholders4592SanBio Company LimitedPharmaceuticals

Notice of Convocation of the 13th Annual General Meeting of Shareholders

The 13th Annual General Meeting of Shareholders will be held on 22 April 2026, with the election of 1 director and the reduction of stated capital and capital reserves, together with the disposition of surplus, submitted for approval.

Worth reading
62In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
3408791083
¥
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (13th)
2026
Apr 22
Date and time(registration opens at 9:00 a.m.)22 days from this disclosure to the meeting
Matters for resolution2 items
  1. Election of 1 director

  2. Reduction in the amount of stated capital and capital reserves, and disposition of surplus

Shareholder Proposal

None (not specified)

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee
1Nominees
1New
1Outside
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (13th)
Date and time10:00 a.m. on Wednesday, 22 April 2026 (registration opens at 9:00 a.m.)
Matters for resolutionProposal No. 1: Election of 1 director, Proposal No. 2: Reduction in the amount of stated capital and capital reserves, and disposition of surplus
Shareholder ProposalNone (not specified)
Director nominee1 candidate, including 1 new candidate and 1 outside candidate
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To reduce the tax burden through a reduction in stated capital and capital reserves, strengthen the financial position by offsetting the accumulated deficit, and ensure flexibility in capital policy, including future shareholder returns.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 13th Annual General Meeting of Shareholders | SanBio Company Limited (4592) timely disclosure | Komori